Patents by Inventor Steven R. Goldring

Steven R. Goldring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM
    Publication number: 20220008543
    Abstract: This application discloses prodrug-based thermosensitive gel (“ProGel”) comprised of conjugates of dmg molecules with water-soluble polymeric carriers, which are capable of controlled release of the dmg molecules into the tissue of a subject. Use of the ProGel-Drug conjugates for treatment of various diseases or disorders and methods of preparing them are also disclosed.
    Type: Application
    Filed: October 27, 2019
    Publication date: January 13, 2022
    Inventors: Dong Wang, Steven R. Goldring, Gang Zhao, Rongguo Ren, Zhenshan Jia, Xin Wei
  • Macromolecular Prodrugs for Hard Tissue and Methods of Use Thereof
    Publication number: 20150202313
    Abstract: Methods and compositions for treating bone disorders are disclosed.
    Type: Application
    Filed: September 3, 2013
    Publication date: July 23, 2015
    Inventors: Dong Wang, Zhenshan Jia, Yijia Zhang, Steven R. Goldring, Aaron Daluiski
  • Compositions and Methods for Detecting and Treating Implant Loosening and Osteolysis
    Publication number: 20120189543
    Abstract: Methods and compositions for detecting, diagnosing, and treating osteolysis and implant loosening are disclosed.
    Type: Application
    Filed: September 9, 2010
    Publication date: July 26, 2012
    Inventors: Dong Wang, Steven R. Goldring, Edward V. Fehringer
  • Nucleic acids encoding calcitonin receptor and uses thereof
    Patent number: 5516651
    Abstract: Recombinant DNA which encodes a calcitonin receptor polypeptide, vectors and hosts containing the recombinant DNA, and methods for expressing a calcitonin receptor polypeptide from the recombinant DNA are described.
    Type: Grant
    Filed: November 15, 1991
    Date of Patent: May 14, 1996
    Assignee: The General Hospital Corporation
    Inventors: Steven R. Goldring, Alan H. Gorn, Herb Y. Lin